임상 표준실험실 시장 보고서(2026년)
Clinical Reference Laboratory Global Market Report 2026
상품코드 : 1942571
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,655,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,619,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,583,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

임상 표준실험실 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 470억 달러에서 2026년에는 502억 4,000만 달러로, CAGR 6.9%로 확대할 전망입니다. 지난 수년간 성장 요인으로는 만성질환 유병률 증가, 병원 진단 업무의 외주화, 감염성 질환 검사 수요 증가, 규제 준수 필요성, 검사실 통합 등을 꼽을 수 있습니다.

임상 표준실험실 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 649억 3,000만 달러에 달하며, CAGR은 6.6%에 달할 전망입니다. 예측 기간의 성장 요인으로는 게놈 검사 확대, AI 기반 진단 기술 도입, 맞춤형 의료의 발전, 의료의 디지털화, 집단 건강검진 수요 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 분자진단의 확대, 검사 자동화, 고난이도 검사의 성장, 신속한 진단 결과 제공에 대한 수요, 진단 서비스의 집중화 등을 꼽을 수 있습니다.

진단 검사에 대한 수요 증가는 향후 임상검사 시장 확대를 견인할 것으로 예측됩니다. 진단검사는 질병, 병증, 감염증의 검출, 진단, 경과 관찰을 목적으로 하는 생물학적 검체 분석을 말합니다. 이러한 수요 급증은 주로 검사의 접근성, 정확성, 효율성을 향상시킨 의료기술의 발전이 주요 원인으로 분석됩니다. 임상검사센터는 첨단 기술과 표준화된 프로토콜을 통해 전문적이고 정밀한 분석을 제공하며, 진단검사에서 매우 중요한 역할을 담당하고 있습니다. 이들 검사센터는 다양한 의료분야에서 질병의 조기발견, 치료계획 수립, 환자 경과관찰에 필수적인 신뢰할 수 있는 검사결과를 보장합니다. 예를 들어 2024년 4월 영국 공공 의료 시스템인 국민보건서비스(NHS)가 발표한 보고서에 따르면 주요 진단 검사를 6주 이상 기다리는 환자 수가 37만 6,200명으로 전월 대비 2만 1,200명 증가한 것으로 나타났습니다. 이에 따라 진단검사 수요 증가가 임상검사 시장의 성장을 촉진할 것으로 예측됩니다.

임상검사 시장의 주요 기업은 효율성, 정확성, 확장성 향상을 위해 자동화 시료 처리 플랫폼과 같은 첨단 제품 개발에 주력하고 있습니다. 자동화 시료 처리 플랫폼은 로봇 기술과 첨단 소프트웨어를 활용하여 최소한의 인위적 개입으로 생물학적 시료의 취급, 시료 준비 및 분석을 수행하는 고처리량 검사 시스템입니다. 이를 통해 진단 및 연구 워크플로우의 효율성, 정확성, 표준화를 보장합니다. 예를 들어 2023년 1월 분자진단용 샘플 분석 기술을 제공하는 독일 기업 QIAGEN NV는 진단실험실용 'EZ2 Connect MDx' 플랫폼을 발표했습니다. EZ2 Connect MDx는 자동 시료 처리를 위한 체외진단용 의료기기(IVD) 플랫폼으로, 단 30분 만에 24개 시료 분량의 DNA 및 RNA를 동시에 효율적으로 정제할 수 있습니다. 혈장, 혈청, 대변 등 다양한 시료 유형에서 핵산 추출을 위해 마그네틱 비드 기술을 채택하고 있습니다. 이 플랫폼은 사전 충전 및 밀봉된 시약 카트리지, 로드 체크용 내장 카메라, 공정 안전성을 보장하고 오염 위험을 줄이기 위한 UV 오염 제거 기능을 갖추고 있습니다. 또한 온보드 피펫팅, 가열, 밀봉 카트리지 자동 천공 기능을 탑재하여 원활한 작동을 실현합니다. 얻어진 분석물은 실시간 PCR, 디지털 PCR, 차세대 시퀀싱 등 여러 다운스트림 기술에 대응하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

A clinical reference laboratory is a specialized facility that conducts high-complexity diagnostic testing and analysis on biological samples, including blood, urine, and tissue. These labs provide advanced testing services such as molecular diagnostics, toxicology, immunology, and pathology. They are equipped with cutting-edge technology and follow strict regulatory standards to ensure the accuracy, reliability, and compliance of their results with healthcare regulations.

The main types of clinical reference laboratories include clinical chemistry, genetics testing, microbiology, cytology, and others. Clinical chemistry, a branch of clinical pathology, focuses on the quantitative analysis of bodily fluids such as blood and urine to determine the concentration of various chemical substances. This field employs a range of technologies, from traditional laboratory methods to digital technologies, automated testing platforms, and molecular diagnostics, and is utilized by clinics, hospitals, and independent labs.

Tariffs have increased costs of reagents, diagnostic instruments, and automated testing platforms, affecting molecular diagnostics and genetics testing. Asia-Pacific and North America are most impacted. However, tariffs are driving local reagent production and laboratory automation investments.

The clinical reference laboratory market research report is one of a series of new reports from The Business Research Company that provides clinical reference laboratory market statistics, including clinical reference laboratory industry global market size, regional shares, competitors with a clinical reference laboratory market share, detailed clinical reference laboratory market segments, market trends and opportunities, and any further data you may need to thrive in the clinical reference laboratory industry. This clinical reference laboratory market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical reference laboratory market size has grown strongly in recent years. It will grow from $47 billion in 2025 to $50.24 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to chronic disease prevalence, hospital diagnostic outsourcing, infectious disease testing demand, regulatory compliance needs, laboratory consolidation.

The clinical reference laboratory market size is expected to see strong growth in the next few years. It will grow to $64.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to genomic testing expansion, AI-based diagnostics adoption, personalized medicine growth, healthcare digitization, population health screening demand. Major trends in the forecast period include expansion of molecular diagnostics, automation of laboratory testing, growth of high-complexity testing, demand for rapid diagnostic turnaround, centralization of diagnostic services.

The growing demand for diagnostic testing is expected to drive the expansion of the clinical reference laboratory market in the future. Diagnostic testing involves analyzing biological samples to detect, diagnose, and monitor diseases, medical conditions, or infections. This surge in demand for diagnostic testing is largely due to advancements in medical technology, which have made tests more accessible, accurate, and efficient. Clinical reference laboratories play a crucial role in diagnostic testing, offering specialized and precise analysis through advanced technologies and standardized protocols. These laboratories ensure reliable test results that are critical for early disease detection, treatment planning, and patient monitoring across a variety of medical fields. For example, in April 2024, a report from the National Health Service (NHS), the UK's publicly funded healthcare system, revealed that 376,200 patients were waiting over six weeks for a key diagnostic test, marking an increase of 21,200 from the previous month. As a result, the growing demand for diagnostic testing is expected to drive the clinical reference laboratory market's growth.

Key players in the clinical reference laboratory market are focusing on developing advanced products, such as automated sample processing platforms, to improve efficiency, accuracy, and scalability. Automated sample processing platforms are high-throughput laboratory systems that use robotics and advanced software to handle, prepare, and analyze biological samples with minimal human intervention, ensuring efficiency, accuracy, and standardization in diagnostic and research workflows. For example, in January 2023, QIAGEN NV, a Germany-based provider of sample and assay technologies for molecular diagnostics, launched the EZ2 Connect MDx platform for diagnostic laboratories. The EZ2 Connect MDx is an IVD platform designed for automated sample processing, allowing laboratories to efficiently purify DNA and RNA from 24 samples simultaneously in as little as 30 minutes. It utilizes magnetic-bead technology for nucleic acid extraction from various sample types, including blood plasma, serum, and stool. The platform is equipped with prefilled, sealed reagent cartridges, integrated cameras for load checking, and UV decontamination features to ensure process safety and reduce contamination risks. Additionally, it includes onboard pipetting, heating, and automated piercing of sealed cartridges for seamless operation. The resulting analyte is compatible with multiple downstream technologies, such as real-time PCR, digital PCR, and next-generation sequencing.

In April 2024, Eurofins Scientific, a Luxembourg-based testing laboratory company, acquired Ascend Clinical LLC for an undisclosed amount. This acquisition enables Eurofins Scientific to enhance its presence in renal and transplant testing by integrating Ascend Clinical's expertise, advanced laboratory services, and established client base with Eurofins' extensive network, technological capabilities, and industry relationships. This merger is expected to improve diagnostic offerings, enhance patient care, and drive growth in the clinical diagnostics sector across the United States. Ascend Clinical LLC is a U.S.-based provider of clinical reference laboratory testing and services.

Major companies operating in the clinical reference laboratory market are Mayo Clinic Laboratories, Eurofins Scientific, Quest Diagnostics, Sonic Healthcare, Unilabs, ARUP Laboratories, Lancet Laboratories, NeoGenomics Laboratories, Ampath Laboratories, Clinical Reference Laboratory, Al Borg Medical Laboratories, Medsol Diagnostics, Medlabs Group, Cerba International, Lifebrain Group, CRL Diagnostics, Dr. Lal PathLabs, SRL Diagnostics, Synlab International, ACM Global Laboratories, Laboratory Corporation of America (Labcorp), KingMed Diagnostics

North America was the largest region in the clinical reference laboratory market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical reference laboratory market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical reference laboratory market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The clinical reference laboratory market consists of revenues earned by entities by providing services such as pathology services, biomarker testing and pharmacogenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical reference laboratory market also includes sales of diagnostic test kits, blood collection tubes, microbiology culture media and immunoassay reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Reference Laboratory Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses clinical reference laboratory market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for clinical reference laboratory ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical reference laboratory market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Clinical Reference Laboratory Market Characteristics

3. Clinical Reference Laboratory Market Supply Chain Analysis

4. Global Clinical Reference Laboratory Market Trends And Strategies

5. Clinical Reference Laboratory Market Analysis Of End Use Industries

6. Clinical Reference Laboratory Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Clinical Reference Laboratory Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Clinical Reference Laboratory Total Addressable Market (TAM) Analysis for the Market

9. Clinical Reference Laboratory Market Segmentation

10. Clinical Reference Laboratory Market Regional And Country Analysis

11. Asia-Pacific Clinical Reference Laboratory Market

12. China Clinical Reference Laboratory Market

13. India Clinical Reference Laboratory Market

14. Japan Clinical Reference Laboratory Market

15. Australia Clinical Reference Laboratory Market

16. Indonesia Clinical Reference Laboratory Market

17. South Korea Clinical Reference Laboratory Market

18. Taiwan Clinical Reference Laboratory Market

19. South East Asia Clinical Reference Laboratory Market

20. Western Europe Clinical Reference Laboratory Market

21. UK Clinical Reference Laboratory Market

22. Germany Clinical Reference Laboratory Market

23. France Clinical Reference Laboratory Market

24. Italy Clinical Reference Laboratory Market

25. Spain Clinical Reference Laboratory Market

26. Eastern Europe Clinical Reference Laboratory Market

27. Russia Clinical Reference Laboratory Market

28. North America Clinical Reference Laboratory Market

29. USA Clinical Reference Laboratory Market

30. Canada Clinical Reference Laboratory Market

31. South America Clinical Reference Laboratory Market

32. Brazil Clinical Reference Laboratory Market

33. Middle East Clinical Reference Laboratory Market

34. Africa Clinical Reference Laboratory Market

35. Clinical Reference Laboratory Market Regulatory and Investment Landscape

36. Clinical Reference Laboratory Market Competitive Landscape And Company Profiles

37. Clinical Reference Laboratory Market Other Major And Innovative Companies

38. Global Clinical Reference Laboratory Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Clinical Reference Laboratory Market

40. Clinical Reference Laboratory Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기